NRXPW
NRx Pharmaceuticals IncNASDAQ
Key Statistics
Market Cap
$714.61M
P/E Ratio
—
EPS
$-6.25
Beta
2.02
52W High
$0.17
52W Low
$0.00
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About NRx Pharmaceuticals Inc
NRx Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company, develops new treatments for the treatment of life-threatening central nervous system disorders and lung diseases. The company is headquartered in Wilmington, Delaware.
Fundamentals
| Revenue (TTM) | $2.29M |
| Gross Profit (TTM) | $1.16M |
| EBITDA | $-17.06M |
| Operating Margin | -444.60% |
| Return on Equity | -683.00% |
| Return on Assets | -110.20% |
| Revenue/Share (TTM) | $0.09 |
| Book Value | $-0.41 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $28.00M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 5/25/2026